Celltrion, which sells a cheap version of a top-selling rheumatoid arthritis drug in Europe, is now setting its sights on the U.S.
WSJ.com: Asia Home, Wall Street Journal: Home Asia
Tue, 03/31/2015 - 11:40pm
Celltrion, which sells a cheap version of a top-selling rheumatoid arthritis drug in Europe, is now setting its sights on the U.S.